Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2025-02-27 Capital/Financing Update
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Cleansing Notice - Placement 2 pages 237.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement regarding the issuance of new shares by 4DMedical Limited under section 708A(5)(e) of the Corporations Act. It details the number of shares issued, the price, the placement, and compliance with relevant sections of the Corporations Act. There is no financial report, earnings data, or management discussion. The document is a formal notification about a capital raising event and share issuance, which fits the category of Capital/Financing Update (CAP). The document length is 3649 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2025-02-27 English
Change in substantial holding 4 pages 269.6KB
Major Shareholding Notification Classification · 100% confidence The document is an ASX announcement titled 'Form 604 – Notice of change of interests of substantial holder' dated 28 February 2025. It references Section 671B of the Corporations Act 2001 and details changes in voting power and relevant interests of substantial holders in 4DMedical Limited. The content includes detailed tables of shareholdings, dilution events, and associations of substantial holders. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not a report, earnings release, or management information, but a regulatory disclosure about shareholding changes.
2025-02-27 English
Change in substantial holding 3 pages 194.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, specifically a "Notice of change of interests of substantial holder." It details changes in voting power, relevant interests, and associations of a substantial shareholder in the company 4DMedical Limited. The form includes dates of changes, shareholdings, and legal references to the Corporations Act sections relevant to substantial holdings and voting rights. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2025-02-27 English
Change in substantial holding 3 pages 185.2KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, specifically Section 671B, which pertains to the 'Notice of change of interests of substantial holder.' The content details changes in voting power, relevant interests, and associations of a substantial shareholder in a company, including dates and share quantities. This form is a regulatory filing used to notify the market and regulators about changes in significant share ownership levels. It is not a financial report, earnings release, or management discussion, but a formal notification of shareholding changes. Therefore, the document fits the category of 'Major Shareholding Notification' (MRQ). The document length and detail confirm it is the actual notice, not just an announcement of a report.
2025-02-27 English
Webinar details - 1H FY2025 Half Year Results 2 pages 177.3KB
Investor Presentation Classification · 95% confidence The document is an ASX announcement inviting shareholders and investors to an investor webinar and Q&A session regarding the company's 1H FY2025 Half Year Results. It provides details about the webinar registration and timing but does not contain any actual financial statements or substantive financial data. The document length is 3369 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial analysis or data presented, only an invitation to discuss the half-year results. Therefore, this document is best classified as an Investor Presentation (IP) announcement or invitation rather than the actual Interim/Quarterly Report (IR). Given the content focuses on the investor briefing and webinar, the most appropriate classification is Investor Presentation (IP).
2025-02-26 English
Application for quotation of securities - 4DX 6 pages 18.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from 4DMEDICAL LIMITED regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, references previous announcements (Appendix 3B), and provides information about issued capital following the quotation. The document is a formal application for listing securities rather than a report or financial statement. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement related to capital market activities. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital changes.
2025-02-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.